Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Drug Injury
  • About Our Firm
  • Free Case Evaluation
  • Frequently Asked Questions

Clinical Practice Guidelines for the Management of Malignant Pleural Mesothelioma

August 19, 2020 By Law Offices of Thomas J. Lamb, P.A.

Clinical practice guidelines for the management of malignant pleural mesothelioma were released in May 2020 by the European
Respiratory Society, European Society of Thoracic Surgeons, European Association for Cardio-Thoracic Surgery, and European Society for Radiotherapy and Oncology.

Epidemiology Research Priorities

The task force recommends large international epidemiological studies to determine the relationship between pleural plaques and malignant pleural mesothelioma.

Additionally, well-designed clinical trials are needed to determine the effectiveness of CT screening in populations exposed to asbestos.

Further research is needed, and highly encouraged, on biomarkers for malignant pleural mesothelioma, as the ones proposed previously have not proven useful for diagnosis, prognosis, or clinical follow-up for disease monitoring.

Staging Research Priorities

The task force encourages increased prospective data collection regarding tumor thickness and volume measurements.

Additionally, it encourages the prospective use of volumetric assessment software for pretreatment staging investigations.

Other prognostic factors that are important are routine use of the Brims score, in combination with other scores, as part of clinical trials for prospective validation.

Surgery Recommendations & Research Priorities

The task force recommends thorascopic talc poudrage to control recurrent malignant pleural mesothelioma effusions as their first choice to achieve pleurodesis in patients with expanded lungs.

In symptomatic patients who are stable enough to undergo surgery but who will not benefit from chemical pleurodesis or an indwelling catheter, or in whom these have failed, the task force suggests palliative video-assisted thoracic surgery/partial pleurectomy to obtain pleural effusion control.

Malignant pleural mesothelioma patients who are being considered for radical surgery (eg, extrapleural pneumonectomy or pneumonectomy/decortication) should be included in national/international surgical registries or prospective randomized controlled clinical trials.

[Article continues at original source]

 Asbestos & Mesothelioma Information

  Asbestos-Mesothelioma Case Evaluation
Free.  Confidential.  No Obligation.

Filed Under: Mesothelioma Tagged With: malignant pleural mesothelioma (MPM), mesothelioma, mesothelioma treatments

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Cases
  • Breast Implant Cases
  • Philips Breathing Devices Cases
  • GenX Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2022 · Law Offices of Thomas J. Lamb, P.A.